Evidence map›Paper›PMID 39462593›Full record

ReviewInternal medicine (Tokyo, Japan)2025

Management of Concurrent Immune Thrombocytopenia and Ulcerative Colitis: A Case Report and Literature Review.

Masataka Hirai, Minako Mori, Tomomi Sakai, Tomomi Oka, Yasuhiro Watanabe, Masaki Murata, Koki Moriyoshi, Hiroshi Kawabata

Abstract readCase ReportsReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Internal medicine (Tokyo, Japan), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Masataka HiraiDepartment of Hematology, NHO Kyoto Medical Center, Japan.
Minako MoriDepartment of Hematology, NHO Kyoto Medical Center, Japan.
Tomomi SakaiDepartment of Hematology, NHO Kyoto Medical Center, Japan.
Tomomi OkaDepartment of Hematology, NHO Kyoto Medical Center, Japan.
Yasuhiro WatanabeDepartment of Gastroenterology, NHO Kyoto Medical Center, Japan.
Masaki MurataDepartment of Gastroenterology, NHO Kyoto Medical Center, Japan.
Koki MoriyoshiDepartment of Diagnostic Pathology, NHO Kyoto Medical Center, Japan.
Hiroshi KawabataDepartment of Hematology, NHO Kyoto Medical Center, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We herein report a case of concurrent immune thrombocytopenia (ITP) and ulcerative colitis (UC) that achieved remission following mesalazine treatment. A 16-year-old girl presented with severe thrombocytopenia, abdominal pain, and bloody stool. She was initially diagnosed with ITP and then was treated with prednisolone, resulting in an immediate improvement of symptoms. Upon tapering the steroids, the symptoms recurred, thus leading to a subsequent diagnosis of UC via colonoscopy. Treatment with mesalazine promptly induced the remission of both ITP and UC, which was sustained. We reviewed 24 previously documented cases in which the simultaneous flares of UC and ITP were successfully managed.

Indexed as

Colitis, UlcerativePurpura, Thrombocytopenic, IdiopathicAdolescentAnti-Inflammatory Agents, Non-SteroidalFemaleHumansMesalaminePrednisoloneRemission InductionTreatment OutcomeAnti-Inflammatory Agents, Non-SteroidalMesalaminePrednisoloneidiopathic thrombocytopenic purpuraimmune thrombocytopeniamesalazineulcerative colitis

Identifiers

PMID39462593
PMCPMC12183425

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.